Hepatocytes That Express Variants of Cyclophilin A Are Resistant to HCV Infection and Replication

We identified variants in PPIA that destabilize its product, CypA, and prevent HCV infection and replication. These findings indicate mechanisms by which some cells might be resistant to HCV infection and that CypA is a good therapeutic target.